STOCK TITAN
  1. Home
  2. News
  3. COSM

Cosmos Health Inc - COSM STOCK NEWS

Welcome to our dedicated news page for Cosmos Health (Ticker: COSM), a resource for investors and traders seeking the latest updates and insights on Cosmos Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cosmos Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cosmos Health's position in the market.

News
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
Rhea-AI Summary
Cosmos Health expands C-Sept brand with C-Scrub Wash 4% CHG Biocide, expecting significant growth in revenues and profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.83%
Tags
none
-
News
Cosmos Health Announces Relaunch of bio-bebe(R), its Proprietary Organic Infant Care & Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market
Rhea-AI Summary
Cosmos Health relaunches organic infant care and nutrition brand bio-bebe® after acquiring Cana Laboratories. The relaunch aims to penetrate markets across Europe and beyond. The baby food market is projected to grow from $102.90 billion in 2023 to $161.16 billion by 2030. bio-bebe® products expected to be launched in Q1 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.82%
Tags
none
-
News
Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group
Rhea-AI Summary
Cosmos Health enters strategic collaboration with C.A.PAPAELLINAS Group for distribution of nutraceuticals in Cyprus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
News
Cosmos Health Starts Stock Buyback Program
Rhea-AI Summary
Cosmos Health Inc. announces stock buyback program to enhance shareholder value
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
buyback
-
News
Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023
Rhea-AI Summary
Cosmos Health reaches major inflection point with revenue ramp-up and introduces 2026 guidance. Targeting over $180M in annual revenue and EBITDA in excess of $20M. Completed three acquisitions and made progress in R&D. Nutraceutical brands experiencing market success. Maintains robust balance sheet. Exploring initiatives to enhance shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.34%
Tags
none
-
News
Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04
Rhea-AI Summary
Cosmos Health Inc. reported Q2 2023 revenues of $12.36 million, a decline of 6.4% from the same period last year. Adjusted EBITDA increased by 182% to $0.23 million. Adjusted Net Income increased by 158% to $0.16 million. Property and equipment increased by 488% to $10.7 million. Goodwill and intangible assets increased by 435% to $3.78 million. Total stockholders' equity increased by 12.88% to $44.35 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
earnings
News
Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor
Rhea-AI Summary
Cosmos Health Inc. (NASDAQ:COSM) engages KPMG as its new independent registered public accounting firm, replacing Armanino LLP. KPMG will review the company's Third Quarter Form 10-Q and audit its consolidated financial statements for the fiscal year ended December 31, 2023. CEO Greg Siokas highlights the commitment to transparency, integrity, and adherence to high financial oversight and corporate governance standards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.57%
Tags
management
-
News
Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.97%
Tags
none
-
News
Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million
Rhea-AI Summary
Cosmos Health, a global healthcare group, provided an update on recent developments, reaffirming its commitment to future prospects. The company has a strong balance sheet with negligible debt and a diversified asset base. It holds a valuable Good Manufacturing Practices (GMP) license and owns a portfolio of branded nutraceuticals. The management team believes in attractive growth prospects driven by acquisitions, R&D progress, and the constant growth of its nutraceutical brands. The company recently raised $5.25 million in a direct offering and private placement, which will be used for working capital, acquisitions, and general corporate purposes. CEO Greg Siokas has invested over $850,000 in the company this year and has demonstrated unwavering commitment by investing over $15 million since its inception.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.95%
Tags
none
News
Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
offering
Stock COSM logo
Cosmos Health Inc

Nasdaq:COSM

COSM Rankings

N/A Ranked by Market Cap
#4 Ranked by Stock Gains
N/A Ranked by Dividends

COSM Stock Data

11.88M
10.69M
13.05%
11.61%
3.25%
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Wholesale Trade
Link
United States
Chicago